The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 967 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
| ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 7,200 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | |||
| ALLERGAN PLC | SHS | G0177J108 | 42,089 | 257,300 | SH | SOLE | 257,300 | 0 | 0 | |||
| APRICUS BIOSCIENCES INC | COM NEW | 03832V307 | 2,664 | 1,447,906 | SH | SOLE | 1,447,906 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 131,842 | 413,858 | SH | SOLE | 413,858 | 0 | 0 | |||
| BIOVERATIV INC | COM | 09075E100 | 62,816 | 1,165,000 | SH | SOLE | 1,165,000 | 0 | 0 | |||
| INNOVIVA INC | COM | 45781M101 | 51,945 | 3,660,705 | SH | SOLE | 3,660,705 | 0 | 0 | |||
| INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 10,649 | 182,300 | SH | SOLE | 182,300 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | COM CLA | 46333X108 | 24,733 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | |||
| MEDICINES CO | COM | 584688105 | 52,547 | 1,922,000 | SH | SOLE | 1,922,000 | 0 | 0 | |||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 3,198 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | |||